elfabrio
(pegunigalsidase alfa)Chiesi USA, Inc.
Usage: ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease.
3 results
fabrazyme
(AGALSIDASE BETA)Genzyme CorporationUsage: FABRAZYME® is indicated for the treatment of adult and pediatric patients aged 2 years and older who have confirmed Fabry disease.galafold
(migalastat hydrochloride)Amicus Therapeutics US, LLCUsage: GALAFOLD is indicated for treating adults with a confirmed diagnosis of Fabry disease and an amenable GLA gene variant. The indication is based on accelerated approval following a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval may require further clinical benefit verification.